7am to 8am





8am to 8.20am

Dr. Scott Kaatz

 Important Recent Articles in Anticoagulation

8.20am to 8.40am

Dr. Ahmed Mahfouz

Updates from New Guidelines

8.40am to 9am

Dr. Sajad A Hayat

DOACS in Cardioversion

9am to 9.20am

Dr. Naveed Akhtar

Anticoagulation Options after Stroke/TIA

9.20am to 9.40am

Dr. Steve Deitelzweig

ICH and When to Resume Oral Anticoagulants

9.40am to 10am

Q &A -Break

10am to 10.20am

Dr. Shahul Hameed

Anticoagulation in Atrial Fibrillation and Co-existents

Chronic Kidney Disease: Efficacy versus Safety

10.20am to 10.40am

Dr. Geoff Barnes

Use of Triple Antithrombotic in MI Secondary Prevention

 10.40am to 11am

Dr. Daniel Rainkie

Use of Oral Anticoagulants in CAD and PAD

11am to 11.20am

Dr. Amr Fahmi

DOACs in Valve Disease and Valvular Replacement

11.20am to 11.30am

Q &A

11.20am to 1.30pm

Lunch / (Jummah Prayer at Hotel)

Afternoon Session

1.3pm to 1.50pm

Dr. Hazem Elewa

“Warfarin Pharmacogenetics: What do results from recent linical trials mean?”

1.50pm to 2.10pm

Dr. Mohammed Salem


2.10pm to 2.20pm

Dr Amr Fares

Results of Endogenous Laser Ablation in Patients with Combined Superficial and Deep Venous Pathology

2.20pm to 2.30pm


2.30pm to 2.50pm

Coffee break

2.50pm to 3.10pm

Dr. Scott Kaatz

AC Forum Mission

3.10pm to 3.30 pm

Dr. Steve Deitelzweig

 Real World Data in Non-valvular Atrial Fibrillation

3.30pm to 3.50pm

Dr. Mohammed Mohsen

Ablation and the Role of Anticoagulants

3.50pm to 4.10pm

Dr. Ahmed Shaaban

Use of Technology to Assist Thrombus Detection in Cardiac Patients

4.10pm to 4.30pm

Dr. Nidal Asaad

DOACs Perioperative Management

4.30pm to 4.40pm


 Friday Workshop

Workshop 1


Challenging Cases in Cardiology
Dr. Abdulrahman Arabi ­

Workshop 2

1.30pm to 3.30pm

Management of VTE
Dr. Abdelnasser Elzouki ­